646
Participants
Start Date
January 16, 2019
Primary Completion Date
December 31, 2021
Study Completion Date
February 15, 2022
dyspnea grade ≥ II according NYHA-WHO
"Intervention Investigator from each center will recover consecutives PE patients and collect baseline, demographic and comorbidities.~In all patients enrolled in the study a short questionnaire regarding dyspnea symptoms will be performed. All patients that refer dyspnea grade ≥ II according NYHA-WHO (6) modified scale will be cited as outpatient to be evaluated~Imaging studies and right heart catheterization is the procedure agreeing with the standard care according to current ESC/ERS Guidelines.~In all patients, the following tests will be performed:~1. Pulsioximetry.~2. Electrocardiogram.~3. Blood sample with determination of NT-ProBNP.~4. Echocardiography. Only an echocardiography indicative of PH warrants further evaluation~5. V/Q scintigraphy. Possible CTEPH can be assumed when mismatched perfusion defects are detected by VQ scan.~6. Right heart catheterization \& Pulmonary CT Scan are required for confirming the diagnosis"
Hospital Virgen del Rocio, Seville
Hospital Universitario Puerto Real, Puerto Real
Consorcio Hospitalario Provincial de Castellón, Castellon
Hospital de Galdakao, Galdakao
Hospital General Universitario de Albacete, Albacete
Hospital Universitario de Bellvitge, Barcelona
Parc Sanitari Sant Joan de Deu, Barcelona
Hospital Universitario Reina Sofía, Córdoba
Hospital Virgen de la Luz, Cuenca
Hospital General Universitario de Elche, Elche
Hospital Universitari de Girona Dr. Josep Trueta, Girona
Hospital Universitari Arnau de Vilanova, Lleida
Hospital Clínico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario Joan XXIII de Tarragona, Tarragona
Hospital Clínico Universitario Lozano Blesa, Zaragoza
Merck Sharp & Dohme LLC
INDUSTRY
Sociedad Española de Neumología y Cirugía Torácica
OTHER
Luis Jara-Palomares, MD
OTHER